The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella Pneumophila

Journal of Infection

Volumn 59, Issue 3, 2009, Pages 222-224

  Nakamura, Shigeki ^a   Yanagihara, Katsunori ^b   Izumikawa, Koichi ^a   Seki, Masafumi ^a   Kakeya, Hiroshi ^a   Yamamoto, Yoshihiro ^a   Senjyu, Hideaki ^c   Saito, Atsushi ^d   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^d JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CIPROFLOXACIN; CORTICOSTEROID; CREATINE KINASE; CREATININE; LACTATE DEHYDROGENASE; MACROLIDE; PAZUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIVELESTAT;

ARTERIAL OXYGEN TENSION; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LEGIONELLA PNEUMOPHILA; LETTER; LUNG ALVEOLUS OXYGEN TENSION; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HUMANS; LEGIONNAIRES' DISEASE; MACROLIDES; PNEUMONIA, BACTERIAL; TREATMENT OUTCOME;

EID: 69749090710     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.06.008     Document Type: Letter

References (15)

1. Stout J.E., and Yu V.L. Legionellosis. N Engl J Med 337 (1997) 682-687
2. Diederen B.M. Legionella spp. and Legionnaires' disease. J Infect 56 (2008) 1-12
3. Falco V., Fernandez de Sevilla T., Alegre J., Ferrer A., and Martinez Vazquez J.M. Legionella pneumophila. A cause of severe community-acquired pneumonia. Chest 100 (1991) 1007-1011
4. Meyer R.D., and Finegold S.M. Legionnaires' disease. Annu Rev Med 31 (1980) 219-232
5. Schulin T., Wennersten C.B., Ferraro M.J., Moellering Jr. R.C., and Eliopoulos G.M. Susceptibilities of Legionella spp. to newer antimicrobials in vitro. Antimicrobial Agents Chemother 42 (1998) 1520-1523
6. Walz A., Nichterlein T., and Hof H. Excellent activity of newer quinolones on Legionella pneumophila in J 774 macrophages. Zentralbl Bakteriol 285 (1997) 431-439
7. Unertl K.E., Lenhart F.P., Forst H., Vogler G., Wilm V., Ehret W., et al. Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin. Am J Med 87 (1989) 128S-131S
8. Haranaga S., Toyama M., Arakaki N., Miyara T., Shinzato T., Koide M., et al. Legionella pneumophila pneumonia successfully treated with intravenous ciprofloxacin. Intern Med 41 (2002) 1024-1028
9. Edelstein P.H. Antimicrobial chemotherapy for legionnaires' disease; a review. Clin Infect Dis 21 (1995) S265-S276
10. Martin S.J., and Pendland S.L. Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila. J Antimicrob Chemother 41 (1998) 643-648
11. Martin S.J., Pendland S.L., Chen C., Schreckenberger P.C., and Danziger L.H. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. Diagn Microbiol Infect Dis 29 (1997) 167-171
12. Shinkai M., Henke M.O., and Rubin B.K. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 117 (2008) 393-405
13. Giamarellos-Bourboulis E.J. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int J Antimicrob Agents 31 (2008) 12-20
14. Pedro-Botet M.L., Sabria M., Sopena N., Garcia-Nunez M., Dominguez M.J., Reynaga E., et al. Legionnaires' disease and HIV infection. Chest 124 (2003) 543-547
15. Roig J., and Rello J. Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother 51 (2003) 1119-1129